IT consultants: We acutely aware of the challenges that pharma, biotech, and medical device companies face

This Insight is part of our AI in Pharma Series, where we share use cases for AI & automation in a highly regulated reality. With the ongoing migration from the eXtended EudraVigilance Medicinal Product Dictionary (xEVMPD) to the Product Management Service (PMS), companies face the added challenge of ensuring seamless data integration and synchronization. In this Insight, we delve deeper into the challenges of meeting these regulatory demands and present an automated AI solution to solve them.

This Insight, written by Pharma IT Director of Regulatory Affairs (RA) Anne Louise Kirkegaard, highlights the importance of a solid RA strategy for small pharma and biotech companies. Plus tips to ensure market success and compliance.